rs4132601, IKZF1

N. diseases: 9
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Childhood Acute Lymphoblastic Leukemia
261 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.100 1.000 10 2009 2019
Acute lymphocytic leukemia
CUI: C0023449
Disease: Acute lymphocytic leukemia
222 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.050 1.000 5 2014 2019
Adult Acute Lymphocytic Leukemia
CUI: C0751606
Disease: Adult Acute Lymphocytic Leukemia
154 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.040 1.000 4 2014 2019
Precursor Cell Lymphoblastic Leukemia Lymphoma
168 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.820 1.000 4 2009 2019
Acute leukemia
CUI: C0085669
Disease: Acute leukemia
50 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.010 1.000 1 2014 2014
Hyperdiploid B Acute Lymphoblastic Leukemia
13 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.010 1.000 1 2015 2015
Nasopharyngeal carcinoma
CUI: C2931822
Disease: Nasopharyngeal carcinoma
320 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.700 1.000 1 2010 2010
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
21 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.700 1.000 1 2018 2018
LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2
2 0.763 0.240 7 50402906 3 prime UTR variant T/G snv 0.25 0.700 0